# Validation of a Molecular Signature for Early Detection of Colorectal Cancer

> **NCT06738511** · NA · COMPLETED · sponsor: **ADVANCED MARKER DISCOVERY S.L.** · enrollment: 3421 (actual)

## Conditions studied

- Colorectal Cancer Screening
- Advanced Adenomas (AA)

## Interventions

- **DIAGNOSTIC_TEST:** blood sampling
- **OTHER:** stool sampling
- **OTHER:** colonoscopy

## Key facts

- **NCT ID:** NCT06738511
- **Lead sponsor:** ADVANCED MARKER DISCOVERY S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-28
- **Primary completion:** 2021-09-01
- **Final completion:** 2021-09-01
- **Target enrollment:** 3421 (ACTUAL)
- **Last updated:** 2024-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06738511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06738511, "Validation of a Molecular Signature for Early Detection of Colorectal Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06738511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*